Johnson & Johnson stock heads into the open after a 2.3 percent drop

At the close on September 8, 2026, Johnson & Johnson stock finished at USD 268.82 on the NYSE, down 2.33 percent. The move lagged the S&P 500, which Reuters said fell 0.32 percent to 7,693.60.

Johnson & Johnson stock closed at USD 268.82 on the NYSE on September 8, 2026, down 2.33 percent. The move trailed the S&P 500, which fell 0.32 percent to 7,693.60, while Johnson & Johnson also traded below its recent peak after touching an all-time high last week.

September 8, 2026 in numbers

Johnson & Johnson Inc. (ISIN US4781601046, NYSE: JNJ) lost 2.33 percent in the session, and MSN reported that Jim Cramer tied the dip to weakness in the drug group. The same report said the shares were at USD 268.82 and described the broader pharma selloff, with the health care ETF XLV down 1.9 percent.

The report also said Johnson & Johnson paid its USD 1.34 quarterly dividend on September 8. Reuters said the S&P 500 ended the session at 7,693.60 after a broad pullback in U.S. equities.

Today before the open

Johnson & Johnson is due to present at the Psych Congress conference in New Orleans, which runs from September 15 to September 19. MSN said the company had already highlighted new neuropsychiatry data ahead of the event, and the stock will also trade against a market backdrop shaped by U.S. inflation data later this week, according to Reuters.